Advertisement

Topics

FDA to grant ‘voluntary action indicated’ classification to B+L

16:00 EDT 17 Aug 2017 | Healio

The FDA will issue a “voluntary action indicated” inspection classification for Valeant’s Bausch + Lomb manufacturing plant in Tampa, Florida, according to a company press release.This development will eliminate manufacturing uncertainties related to the facility’s regulatory submissions, the release said.

Original Article: FDA to grant ‘voluntary action indicated’ classification to B+L

NEXT ARTICLE

More From BioPortfolio on "FDA to grant ‘voluntary action indicated’ classification to B+L"

Advertisement
Quick Search
Advertisement
Advertisement